Industry

Natco Pharma Q1 net declines 28% to ₹480 cr on pricing pressure in U.S.  

Incurred increased R&D expenses on account of high value projects, the drugmaker said as revenue dips more than 1% to ₹1,390.6 crore 

Kartavya NewsKartavya News
Aug 13, 2025 - 05:30
 0
Natco Pharma Q1 net declines 28% to ₹480 cr on pricing pressure in U.S.  
Incurred increased R&D expenses on account of high value projects, the drugmaker said as revenue dips more than 1% to ₹1,390.6 crore 
Read More

Tags:

Previous Article

AI startup Perplexity makes $34.5-billion bid for Google's Chrome browser

Next Article

Bhubaneswar-based CIFA to lead multi-country effort to improve livelihood of aqu...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Kartavya News
Kartavya News

Related Posts

ED records statement of Reliance Group chairman Anil Ambani

ED records statement of Reliance Group chairman Anil Am...

Kartavya News Aug 6, 2025  0

Apple hits record India revenue in June quarter, sees $1.1 billion September quarter tariff costs overall

Apple hits record India revenue in June quarter, sees $...

Kartavya News Aug 1, 2025  0

Sundram Fasteners Q1 standalone net up 5%, amid challenging export market

Sundram Fasteners Q1 standalone net up 5%, amid challen...

Kartavya News Aug 1, 2025  0